The continued quest for an 'ideal anticoagulant' led to the US FDA's recent approval of dabigatran etexilate, a prodrug for dabigatran (Pradaxa®, Boehringer Ingelheim), rivaroxaban, a Factor Xa ...

A new class of anticoagulant drugs on the horizon is taking fresh aim at one of cardiology’s toughest challenges: how to prevent blood clots that cause heart attacks and strokes, without leaving ...

Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

Atrial fibrillation (AF) is a common heart condition that affects about one in three people at some point in their lives. It ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Are you searching for effective medications to treat 'Anticoagulants'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...

Glenmark Pharmaceuticals on Tuesday said its US arm has launched anticoagulant Phytonadione injectable emulsion.   Glenmark ...

The rejection of the drug, marketed as AndexXa in the US, means that Boehringer Ingelheim’s Pradaxa (dabigatran) remains the only new anticoagulant on the market with a reversal agent available.

ANY new therapeutic agent brings with it ... 1,2 Earlier, we observed that anticoagulated patients receiving this drug tended to require lower anticoagulant dosages (this has been reported by ...

Physicians should also carefully explain to the patients the potential benefits and some adverse reactions, such as dyspepsia with dabigatran, associated with these new oral agents and the ...